相关实验视频
Updated: Sep 14, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
862
在基因组编辑中,由Cas-sgRNA-DNA复合体的内在特性驱动的非目标序列变异
Celine Kurniawan1, Takeshi Itoh1,2
1Master Program in Global Agriculture Technology and Genomic Science, International College, National Taiwan University, Taipei, Taiwan.
PloS one
|July 18, 2025
概括
了解基因组编辑非目标突变对于安全至关重要. 这项研究揭示了内在的Cas-sgRNA-DNA复杂性质在很大程度上决定了目标外模式,为改进的计算预测工具铺平了道路.
科学领域:
- 生物技术是生物技术.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 基因组编辑技术提供了巨大的生物技术潜力,但也带有诸如非目标突变等风险.
- 准确识别和最小化非目标突变对于安全有效的基因组编辑至关重要.
- 目前用于预测非目标突变的计算工具由于对其特征的不完全理解,其性能有限.
研究的目的:
- 分析经过实验验证的目标外突变数据,以更好地了解它们的特征.
- 开发和验证一种新的计算方法,用于评估目标以外的地点的相似性和多样性.
- 为提高基因组编辑非目标突变的计算预测工具的准确性提供见解.
主要方法:
- 从六项研究中收集和分析了177个实验验证的非目标突变的非冗余数据集.
- 开发了一种统计方法,比较对齐的目标序列的有序相对值,以评估序列模式的相似性和多样性.
- 对基于欧几里德距离和皮尔森相关系数的方法验证了开发的方法.
主要成果:
- 开发的方法与现有方法有很强的相关性,证实了它的有效性.
- 对238个数据集对的分析显示了在各种实验条件 (细胞系,独立实验) 中的一致的非目标序列模式.
- Cas-sgRNA-DNA复合体的内在性质似乎是分裂部位的主要决定因素,尽管新型酶可能表现出独特的模式.
结论:
- 非目标突变模式在很大程度上受基因组编辑复杂的固有特征的支配.
- 新工程或多种细菌来源的酶可能会呈现出独特的非目标配置文件,需要进行特定的评估.
- 这些发现将有助于开发更准确的计算工具,用于预测和减轻基因组编辑中的非目标突变.
更多相关视频
相关概念视频
CRISPR/Cas9 Genome Editing
258
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
258
Homologous Recombination
52.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.3K
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Genome Copying Errors
4.4K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.
4.4K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K

